Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

• Status: NOT_YET_RECRUITING
• Trial end date: 2028-06-30

Summary

This trial aims to study the role of Ivonescimab combined with chemoradiotherapy in high-Risk locoregionally advanced nasopharyngeal carcinoma.

• Phase: PHASE2

Details

• Lead Sponsor: Sun Yat-sen University